Pure Global AI
ANVISA registration 10154450180Active

ANTI-HUMAN GLOBULIN (COOMBS)

ANVISA Registration Number: 10154450180FRESENIUS HEMOCARE BRASIL LTDA.FRESENIUS HEMOCARE BRASIL LTDA.Risk Class III
Verified
Device names
Technical name
ANTI-HUMAN GLOBULIN (COOMBS)
View exact technical-name matches →
PT: GLOBULINA ANTI-HUMANA (COOMBS)
Commercial name
Soro de Coombs
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
10154450180
Process Number
25351365385201757
CNPJ
49601107000184
Company information
Registration Holder
FRESENIUS HEMOCARE BRASIL LTDA.
Manufacturer
FRESENIUS HEMOCARE BRASIL LTDA.
Manufacturing Country
Brazil
PT: BRASIL
Dates and status
Publication Date
Nov 27, 2017
Status
Active
About this record

Access comprehensive regulatory information for ANTI-HUMAN GLOBULIN (COOMBS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10154450180 and manufactured by FRESENIUS HEMOCARE BRASIL LTDA.. The registration is held by FRESENIUS HEMOCARE BRASIL LTDA. with validity until Nov 27, 2027.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.